slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 21,931-21,960
Pages 885
Rows per page 30
Arc
21,931-21,960 of 26,550
09
The slide uses a numbered list format to present strategic pillars.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
16
The chart uses a vertical axis to imply a safety spectrum (Safest to Riskiest) and a horizontal axis for efficacy (clinical remission %).Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Aha Moment1 hit
17
The slide uses a checkmark/arrow matrix to highlight competitive differentiation.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Aha Moment1 hit
18
The slide uses a standard antibody diagram to annotate specific engineering improvements.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Aha Moment1 hit
19
Includes structural visualization of the epitope and two dose-response curves.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Aha Moment1 hit
20
The chart shows dose-response curves for three donors; the table summarizes the calculated EC50 values.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
21
The chart uses a log-linear scale for concentration over time to demonstrate the beta-elimination phase.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
22
The slide uses a bar chart to compare pharmacokinetic properties between a proprietary drug candidate (SPY001) and a competitor (Entyvio).Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
Uses a visual timeline/comparison to contrast current standard of care with the proposed product.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
The slide uses a bar chart to show benchmark data alongside a specific exposure-response analysis for vedolizumab.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Need1 hit
19
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Satisfaction1 hit
04
Uses a visual icon array to represent the '1 in 4' statistic.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style chart to show the progress of various drug candidates through clinical development stages.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
06
The slide uses a circular process diagram for the strategy and a horizontal bar chart to visualize the extension of market protection.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
07
MindMed | Investor Presentation Deck | 32 slidesMindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
08
Uses a brain diagram to visually link specific therapeutic areas to clinical evidence points.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Uses scientific visualization to illustrate the drug's effect on brain states.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a process diagram to illustrate the biological mechanism of action.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Uses a nested circle diagram to visualize the funnel of patients from total prevalence to treatment-resistant cases.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The slide uses a linear process framework to describe the clinical care delivery model.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Business Model1 hit
16
The slide uses a timeline framework to map specific digital product categories to stages of drug development.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Business Model1 hit
17
The slide uses a process-oriented table structure to outline the commercialization strategy.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Business Model1 hit
06
The slide uses a numbered list format to categorize the problem into four distinct areas: clinical outcomes, cost/length of stay, reimbursement losses, and readmission penalties.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Problem1 hit
07
Includes medical citations for each claim.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Problem1 hit
08
Includes medical citations at the bottom.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a list of clinical citations at the bottom.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Solution1 hit
15
The slide uses a matrix-like layout to categorize market segments by time horizon.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Market Size1 hit
16
The chart is a Kaplan-Meier survival curve showing the impact of fluid overload on patient outcomes.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
23
Includes a 'Growth Agenda' list and financial status indicators (cash/debt).Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Financials1 hit